Thomas (TJ) Christl
View detailed information about Thomas (TJ) Christl, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Thomas (TJ) Christl, including their role, qualifications, and regulatory activities.
Recent Records (25)
Page 1 of 2WARNING_LETTER - Firsttrustchemicals.com
WARNING_LETTER
WARNING_LETTER - Investra-24hs
WARNING_LETTER
WARNING_LETTER - www.tob-one.com
WARNING_LETTER
WARNING_LETTER - Meds India LTD
WARNING_LETTER
WARNING_LETTER - RX Partners
WARNING_LETTER
WARNING_LETTER - CanaRx Services Inc
WARNING_LETTER
WARNING_LETTER - Arkadiy Kisin/White Forest Solutions
WARNING_LETTER
WARNING_LETTER - Pronet/Eyal Bar Oz
WARNING_LETTER
WARNING_LETTER - Rx-Partners
WARNING_LETTER
WARNING_LETTER - GlavMed
WARNING_LETTER
WARNING_LETTER - Bulk2USA
WARNING_LETTER
WARNING_LETTER - CanAmerica Global
WARNING_LETTER
WARNING_LETTER - Pharmempire
WARNING_LETTER
WARNING_LETTER - Worldwide Drug Store
WARNING_LETTER
WARNING_LETTER - American Pharmacy Group
WARNING_LETTER
WARNING_LETTER - Marks Marine Pharmacy
WARNING_LETTER
WARNING_LETTER - MyRXCash
WARNING_LETTER
WARNING_LETTER - MediPK
WARNING_LETTER
WARNING_LETTER - HA Stores, Ltd
WARNING_LETTER
WARNING_LETTER - 247Med
WARNING_LETTER
Showing 1-20 of 25 records
Related Office
Person Information
Name
Thomas (TJ) Christl
Degree
M.S.
Title
Office Director
Role
Regulatory Personnel
ID: 64bd97de-4180-46e9-a1a9-9b1230abaf24
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox